Is Novavax's COVID Vaccine Authorization in the Philippines a Game-Changer?

·2 min read

Novavax (NASDAQ: NVAX) hasn't won authorization or approvals for its COVID-19 vaccine in major markets yet. In this Motley Fool Live video recorded on Nov. 16, Fool contributors Keith Speights and Brian Orelli answer a viewer's question about whether this authorization in the Philippines could be a game-changer for Novavax.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting